Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Semi-Mechanism-Based Pharmacokinetic-Toxicodynamic Model of Oxaliplatin-Induced Acute and Chronic Neuropathy
Authors
Keywords
-
Journal
Pharmaceutics
Volume 12, Issue 2, Pages 125
Publisher
MDPI AG
Online
2020-02-06
DOI
10.3390/pharmaceutics12020125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peripheral Venous Blood Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Patients With Gastric Cancer Treated With SOX or XELOX Regimen Neoadjuvant Chemotherapy
- (2019) Li Chen et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Retrospective comparison of efficacy and safety of CAPOX and FOLFOX regimens as adjuvant treatment in patients with stage III colon cancer
- (2019) Serkan Degirmencioglu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modeling and simulation of oxaliplatin for hematological toxicity in rats
- (2019) Shinji Kobuchi et al. XENOBIOTICA
- The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
- (2018) Endale Gebreegziabher Gebremedhn et al. BMC CANCER
- Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats
- (2018) M.I. Mas-Fuster et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Evaluation of Antiproliferative Activity, Safety and Biodistribution of Oxaliplatin and 5-Fluorouracil Loaded Lactoferrin Nanoparticles for the Management of Colon Adenocarcinoma: an In Vitro and an In Vivo Study
- (2018) Farhan Ahmed et al. PHARMACEUTICAL RESEARCH
- A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer
- (2017) Sook Ryun Park et al. EUROPEAN JOURNAL OF CANCER
- Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- (2017) Hana Starobova et al. Frontiers in Molecular Neuroscience
- Population Pharmacokinetic–Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats
- (2016) Shinji Kobuchi et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing
- (2015) Mina Nikanjam et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
- (2015) V.A. Carozzi et al. NEUROSCIENCE LETTERS
- Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future
- (2015) A. Avan et al. ONCOLOGIST
- Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
- (2015) Shunsuke Fujita et al. PLoS One
- Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia
- (2014) Quentin Chalret du Rieu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacological Characterization of Standard Analgesics on Oxaliplatin-Induced Acute Cold Hypersensitivity in Mice
- (2014) Meng Zhao et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Pharmacokinetic–pharmacodynamic (PK–PD) modeling and simulation of 5-fluorouracil for erythropenia in rats
- (2014) Shinji Kobuchi et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: Results from a prospective multicenter study
- (2013) Andreas A. Argyriou et al. CANCER
- Morphologic Features and Glial Activation in Rat Oxaliplatin-Dependent Neuropathic Pain
- (2013) Lorenzo Di Cesare Mannelli et al. JOURNAL OF PAIN
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents
- (2011) Soichiro Ushio et al. EUROPEAN JOURNAL OF CANCER
- Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?
- (2010) D. J. Storey et al. ANNALS OF ONCOLOGY
- Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
- (2010) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics and Toxicodynamics of Oxaliplatin in Rats: Application of a Toxicity Factor to Explain Differences in the Nephrotoxicity and Myelosuppression Induced by Oxaliplatin and the Other Platinum Antitumor Derivatives
- (2010) Kazuhiko Hanada et al. PHARMACEUTICAL RESEARCH
- Platinum neurotoxicity pharmacogenetics
- (2009) S. R. McWhinney et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice
- (2009) Punam Gauchan et al. NEUROSCIENCE LETTERS
- The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat
- (2008) Alexia Kagiava et al. NEUROTOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started